In papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC)-derived cell lines, metformin inhibited cancer cell growth and down-regulated cyclin D1 expression. This evidence concerns the gene CCND1 and differentiated thyroid carcinoma.